When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BOLD - Thomas M. Soloway on Satsuma Pharma's board
Audentes Therapeutics Inc.
Satsuma Pharmaceuticals (STSA-0.3%) appointed industry veteran Thomas M. Soloway, currently serving as EVP and COO of Audentes Therapeutics (BOLD), to its board of directors, effective July 2, 2020.
More news on: Satsuma Pharmaceuticals, Inc., Audentes Therapeutics, Inc., Ascendis Pharma A/S, Healthcare stocks news,